Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 1
2006 6
2007 5
2008 10
2009 5
2010 3
2011 7
2012 7
2013 7
2014 9
2015 20
2016 10
2017 11
2018 18
2019 19
2020 7
2021 17
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Khan SA, Zhao F, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, Pockaj BA, Lee CA, Razaq W, Sparano JA, Babiera GV, Dy IA, Jain S, Silverman P, Fisher CS, Tevaarwerk AJ, Wagner LI, Sledge GW. Khan SA, et al. Among authors: golshan m. J Clin Oncol. 2022 Mar 20;40(9):978-987. doi: 10.1200/JCO.21.02006. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995128 Free PMC article. Clinical Trial.
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.
Shepherd JH, Ballman K, Polley MC, Campbell JD, Fan C, Selitsky S, Fernandez-Martinez A, Parker JS, Hoadley KA, Hu Z, Li Y, Soloway MG, Spears PA, Singh B, Tolaney SM, Somlo G, Port ER, Ma C, Kuzma C, Mamounas E, Golshan M, Bellon JR, Collyar D, Hahn OM, Hudis CA, Winer EP, Partridge A, Hyslop T, Carey LA, Perou CM, Sikov WM. Shepherd JH, et al. Among authors: golshan m. J Clin Oncol. 2022 Apr 20;40(12):1323-1334. doi: 10.1200/JCO.21.01506. Epub 2022 Jan 19. J Clin Oncol. 2022. PMID: 35044810 Free PMC article. Clinical Trial.
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER, Golshan M, Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP. Sikov WM, et al. Among authors: golshan m. J Clin Oncol. 2015 Jan 1;33(1):13-21. doi: 10.1200/JCO.2014.57.0572. Epub 2014 Aug 4. J Clin Oncol. 2015. PMID: 25092775 Free PMC article. Clinical Trial.
Surgical Management of Hereditary Breast Cancer.
Berger ER, Golshan M. Berger ER, et al. Among authors: golshan m. Genes (Basel). 2021 Aug 31;12(9):1371. doi: 10.3390/genes12091371. Genes (Basel). 2021. PMID: 34573353 Free PMC article. Review.
Management of In-Breast Tumor Recurrence.
Wong SM, Golshan M. Wong SM, et al. Among authors: golshan m. Ann Surg Oncol. 2018 Oct;25(10):2846-2851. doi: 10.1245/s10434-018-6605-4. Epub 2018 Jun 26. Ann Surg Oncol. 2018. PMID: 29947005 Review.
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Loibl S, O'Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD, Huober J, Golshan M, von Minckwitz G, Maag D, Sullivan D, Wolmark N, McIntyre K, Ponce Lorenzo JJ, Metzger Filho O, Rastogi P, Symmans WF, Liu X, Geyer CE Jr. Loibl S, et al. Among authors: golshan m. Lancet Oncol. 2018 Apr;19(4):497-509. doi: 10.1016/S1470-2045(18)30111-6. Epub 2018 Feb 28. Lancet Oncol. 2018. PMID: 29501363 Clinical Trial.
Immunotherapy Treatment for Triple Negative Breast Cancer.
Berger ER, Park T, Saridakis A, Golshan M, Greenup RA, Ahuja N. Berger ER, et al. Among authors: golshan m. Pharmaceuticals (Basel). 2021 Aug 4;14(8):763. doi: 10.3390/ph14080763. Pharmaceuticals (Basel). 2021. PMID: 34451860 Free PMC article. Review.
De Novo Stage 4 Metastatic Breast Cancer: A Surgical Disease?
Barbie TU, Golshan M. Barbie TU, et al. Among authors: golshan m. Ann Surg Oncol. 2018 Oct;25(11):3109-3111. doi: 10.1245/s10434-018-6664-6. Epub 2018 Jul 17. Ann Surg Oncol. 2018. PMID: 30019303 No abstract available.
Management of the Axilla in Early Breast Cancer.
Valero MG, Golshan M. Valero MG, et al. Among authors: golshan m. Cancer Treat Res. 2018;173:39-52. doi: 10.1007/978-3-319-70197-4_4. Cancer Treat Res. 2018. PMID: 29349757 Review.
147 results